Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington’s Disease Pre-clinical Model

Although several agents have been identified to provide therapeutic benefits in Huntington disease (HD), the number of conventionally used treatments remains limited and only symptomatic. Thus, it is plausible that the need to identify new therapeutic targets for the development of alternative and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Pardo, Alba, Pepe, Giuseppe, Castaldo, Salvatore, Marracino, Federico, Capocci, Luca, Amico, Enrico, Madonna, Michele, Giova, Susy, Jeong, Se Kyoo, Park, Bu-Mahn, Park, Byeong Deog, Maglione, Vittorio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491579/
https://www.ncbi.nlm.nih.gov/pubmed/31068790
http://dx.doi.org/10.3389/fnmol.2019.00100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491579/
https://www.ncbi.nlm.nih.gov/pubmed/31068790
http://dx.doi.org/10.3389/fnmol.2019.00100

Ejemplares similares